<DOC>
	<DOC>NCT02023268</DOC>
	<brief_summary>Comparison of the efficacy and safety of T2762 and Vismed® in the treatment of moderate to severe Dry Eye Syndrome</brief_summary>
	<brief_title>Efficacy and Safety of T2762 and Vismed® in Dry Eye Syndrome</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Keratoconjunctivitis Sicca</mesh_term>
	<mesh_term>Dry Eye Syndromes</mesh_term>
	<criteria>Signed and dated informed consent Male or female aged from ≥ 18 years old. Known Dry Eye Syndrome requiring artificial tears within the last 3 months prior to study selection. Best far corrected visual acuity &lt; 1/10 Severe blepharitis Severe Dry Eye</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>